For Zepbound (tirzepatide), common GI side effects include nausea (24-30%), diarrhea (18-23%), vomiting (8-12%), and constipation (16-17%), with rates varying by dose
(Jan 4, 2026) Psychiatrists perspective on metabolic psychiatry and GLP-1 integration
Neurohormonal regulation of the sympathetic nervous system: new insights into central mechanisms of action
Additionally, Wegovy's effect on delaying gastric emptying may affect the absorption of orally consumed substances, including cannabis edibles
Geographic Availability Available in all 50 states Clinical Oversight and Safety Treatment managed by licensed providers Lab tests are only performed when clinically needed Medication adjusted every 46 weeks Basic support included
It means regulators have assessed its manufacturing, efficacy, adverse-event data, contraindications and benefitrisk profile for defined groups of patients